Remap Consulting GmbH

Remap Consulting GmbH is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: Small business

Academy of Managed Care Pharmacy (AMCP) Dossier Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
Environmental Analysis Research or strategy related to understanding the market (size, competition, reimbursement, challenges, etc.) and is a tool used to understand if a product can be launched in the market.
Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...

Show all 14 in Market Access 8 more

Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
Payer Toolkit Communicate product value to payers utilizing digital and mobile technology (For example, Payer-Facing iPad Models).
Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
Study Start Up Consulting Request for RWE/HEOR/Market Access Study Start Up Consulting
Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Payer Directed Communication Tools (other than Dossiers) Request services related to payer directed communication tools.

Health Technology Assessment Submission (HTA Submission) (DUPLICATE) Conduct a multidisciplinary process that determines the value of a health technology through different points in its lifecycle.

Focus groups (in-person/virtual) Facilitated group discussions to evaluate reactions to concepts, messages, or services. Produces consensus insights and contrasting views used to refine strategy, materials, or offerings.
In-depth interviews (IDIs) One-on-one qualitative interviews conducted with key stakeholders to explore beliefs, decision drivers, and unmet needs. Delivers rich narrative data to inform trial design, product positioning, and message development.
Journey Mapping (Patient, HCP, Payer) Visual representation of stakeholder experiences across disease or treatment timelines. Identifies pain points, decision triggers, and opportunities for engagement or support.
Payer and HTA Expectations Research Engages payers and HTA bodies to uncover evidence needs, pricing thresholds, and access drivers. Informs clinical and economic evidence generation planning.

Show all 24 services 11 more

Quantitative or Qualitative Research Either to understand concepts, thoughts, or experiences with qualitative research or to quantify the problem by generating numerical data or data that can be transformed into usable statistics with quantitative research.

Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.

Work with Remap Consulting GmbH on Scientist.com

For prices, more details, or to contact Remap Consulting GmbH, visit Scientist.com.